Structure

Physi-Chem Properties

Molecular Weight:  664.38
Volume:  668.656
LogP:  2.072
LogD:  2.558
LogS:  -3.278
# Rotatable Bonds:  7
TPSA:  183.21
# H-Bond Aceptor:  11
# H-Bond Donor:  6
# Rings:  6
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.181
Synthetic Accessibility Score:  5.783
Fsp3:  0.889
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.721
MDCK Permeability:  2.8740490961354226e-05
Pgp-inhibitor:  0.603
Pgp-substrate:  0.024
Human Intestinal Absorption (HIA):  0.372
20% Bioavailability (F20%):  0.024
30% Bioavailability (F30%):  0.817

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.084
Plasma Protein Binding (PPB):  77.54784393310547%
Volume Distribution (VD):  0.385
Pgp-substrate:  13.248038291931152%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.132
CYP2C19-inhibitor:  0.002
CYP2C19-substrate:  0.599
CYP2C9-inhibitor:  0.004
CYP2C9-substrate:  0.094
CYP2D6-inhibitor:  0.006
CYP2D6-substrate:  0.123
CYP3A4-inhibitor:  0.038
CYP3A4-substrate:  0.057

ADMET: Excretion

Clearance (CL):  1.227
Half-life (T1/2):  0.804

ADMET: Toxicity

hERG Blockers:  0.094
Human Hepatotoxicity (H-HT):  0.376
Drug-inuced Liver Injury (DILI):  0.029
AMES Toxicity:  0.02
Rat Oral Acute Toxicity:  0.143
Maximum Recommended Daily Dose:  0.685
Skin Sensitization:  0.197
Carcinogencity:  0.028
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.947

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC106760

Natural Product ID:  NPC106760
Common Name*:   Acanthosessilioside E
IUPAC Name:   n.a.
Synonyms:   Acanthosessilioside E
Standard InCHIKey:  XSHGWZNYZFCBPO-NLNWDERISA-N
Standard InCHI:  InChI=1S/C36H56O11/c1-17(2)18-14-23(38)36(31(44)46-30-29(43)28(42)27(41)20(16-37)45-30)13-12-33(5)19(26(18)36)8-9-22-34(33,6)11-10-21-32(3,4)47-24(15-25(39)40)35(21,22)7/h18-24,26-30,37-38,41-43H,1,8-16H2,2-7H3,(H,39,40)/t18-,19+,20+,21-,22-,23-,24+,26+,27+,28-,29+,30-,33+,34+,35-,36+/m0/s1
SMILES:  OC[C@H]1O[C@@H](OC(=O)[C@]23CC[C@@]4([C@@H]([C@H]3[C@@H](C[C@@H]2O)C(=C)C)CC[C@H]2[C@@]4(C)CC[C@@H]3[C@]2(C)[C@@H](CC(=O)O)OC3(C)C)C)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2063160
PubChem CID:   60155055
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0001755] Diterpene glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. Fruits n.a. n.a. PMID[22691179]
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. n.a. n.a. n.a. Database[HerDing]
NPO30633 Acanthopanax sessiliflorus n.a. n.a. n.a. n.a. n.a. n.a. Database[TCM_Taiwan]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT393 Cell Line HCT-116 Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT83 Cell Line MCF7 Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT134 Cell Line SK-BR-3 Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT146 Cell Line SK-OV-3 Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT165 Cell Line HeLa Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT65 Cell Line HepG2 Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT373 Cell Line SK-MEL-5 Homo sapiens IC50 < 10000.0 nM PMID[515387]
NPT113 Cell Line RAW264.7 Mus musculus IC50 > 50000.0 nM PMID[515387]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC106760 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9802 High Similarity NPC224414
0.9712 High Similarity NPC102619
0.9519 High Similarity NPC272242
0.9307 High Similarity NPC94919
0.9245 High Similarity NPC243572
0.8972 High Similarity NPC11035
0.8952 High Similarity NPC287269
0.8909 High Similarity NPC156651
0.8889 High Similarity NPC470543
0.8868 High Similarity NPC88744
0.8807 High Similarity NPC73986
0.8807 High Similarity NPC146563
0.8785 High Similarity NPC91583
0.8785 High Similarity NPC240125
0.8785 High Similarity NPC51947
0.8785 High Similarity NPC473844
0.8727 High Similarity NPC54395
0.8713 High Similarity NPC215570
0.8704 High Similarity NPC27551
0.8704 High Similarity NPC114961
0.8649 High Similarity NPC137414
0.8649 High Similarity NPC469820
0.8649 High Similarity NPC469823
0.8636 High Similarity NPC477944
0.8624 High Similarity NPC204392
0.8624 High Similarity NPC1876
0.8624 High Similarity NPC275668
0.8624 High Similarity NPC240734
0.8624 High Similarity NPC91838
0.8621 High Similarity NPC273962
0.8611 High Similarity NPC8431
0.8558 High Similarity NPC108371
0.8532 High Similarity NPC101450
0.8522 High Similarity NPC156789
0.8519 High Similarity NPC295389
0.8505 High Similarity NPC63023
0.8505 High Similarity NPC95243
0.8496 Intermediate Similarity NPC475632
0.8496 Intermediate Similarity NPC469822
0.8496 Intermediate Similarity NPC239293
0.8496 Intermediate Similarity NPC86020
0.8468 Intermediate Similarity NPC200944
0.8468 Intermediate Similarity NPC73455
0.8462 Intermediate Similarity NPC47113
0.8462 Intermediate Similarity NPC174367
0.8455 Intermediate Similarity NPC470311
0.8455 Intermediate Similarity NPC285410
0.8455 Intermediate Similarity NPC250481
0.8455 Intermediate Similarity NPC263827
0.8455 Intermediate Similarity NPC471251
0.8455 Intermediate Similarity NPC274833
0.8448 Intermediate Similarity NPC160084
0.844 Intermediate Similarity NPC471250
0.8435 Intermediate Similarity NPC475182
0.8411 Intermediate Similarity NPC121566
0.8411 Intermediate Similarity NPC223741
0.8411 Intermediate Similarity NPC100955
0.8407 Intermediate Similarity NPC473304
0.8393 Intermediate Similarity NPC477580
0.8393 Intermediate Similarity NPC116024
0.8393 Intermediate Similarity NPC469821
0.8393 Intermediate Similarity NPC473882
0.839 Intermediate Similarity NPC146456
0.839 Intermediate Similarity NPC469757
0.839 Intermediate Similarity NPC471357
0.839 Intermediate Similarity NPC117702
0.8378 Intermediate Similarity NPC207845
0.8378 Intermediate Similarity NPC472719
0.8376 Intermediate Similarity NPC473474
0.8365 Intermediate Similarity NPC253586
0.8364 Intermediate Similarity NPC129340
0.8364 Intermediate Similarity NPC475317
0.8364 Intermediate Similarity NPC154856
0.8364 Intermediate Similarity NPC52241
0.8349 Intermediate Similarity NPC195708
0.8349 Intermediate Similarity NPC230888
0.8348 Intermediate Similarity NPC475187
0.8348 Intermediate Similarity NPC281840
0.8348 Intermediate Similarity NPC471406
0.8348 Intermediate Similarity NPC108072
0.8333 Intermediate Similarity NPC285927
0.8333 Intermediate Similarity NPC162033
0.8333 Intermediate Similarity NPC473199
0.8319 Intermediate Similarity NPC88945
0.8304 Intermediate Similarity NPC144068
0.8304 Intermediate Similarity NPC260665
0.8291 Intermediate Similarity NPC27363
0.8291 Intermediate Similarity NPC256983
0.8288 Intermediate Similarity NPC31839
0.8286 Intermediate Similarity NPC157739
0.8276 Intermediate Similarity NPC470478
0.8273 Intermediate Similarity NPC218853
0.8273 Intermediate Similarity NPC477070
0.8273 Intermediate Similarity NPC477069
0.8273 Intermediate Similarity NPC473570
0.8273 Intermediate Similarity NPC265655
0.8269 Intermediate Similarity NPC472989
0.8261 Intermediate Similarity NPC319570
0.8261 Intermediate Similarity NPC477071
0.8261 Intermediate Similarity NPC161738
0.825 Intermediate Similarity NPC471361
0.825 Intermediate Similarity NPC251866
0.825 Intermediate Similarity NPC89514
0.825 Intermediate Similarity NPC284406
0.825 Intermediate Similarity NPC70542
0.825 Intermediate Similarity NPC86159
0.825 Intermediate Similarity NPC9499
0.825 Intermediate Similarity NPC219085
0.825 Intermediate Similarity NPC6108
0.825 Intermediate Similarity NPC469754
0.825 Intermediate Similarity NPC471360
0.825 Intermediate Similarity NPC471359
0.825 Intermediate Similarity NPC469752
0.825 Intermediate Similarity NPC197707
0.825 Intermediate Similarity NPC471358
0.825 Intermediate Similarity NPC471352
0.825 Intermediate Similarity NPC469753
0.825 Intermediate Similarity NPC469755
0.825 Intermediate Similarity NPC10823
0.825 Intermediate Similarity NPC469751
0.825 Intermediate Similarity NPC180079
0.825 Intermediate Similarity NPC17896
0.8235 Intermediate Similarity NPC329784
0.8235 Intermediate Similarity NPC240070
0.822 Intermediate Similarity NPC248202
0.8218 Intermediate Similarity NPC269267
0.8214 Intermediate Similarity NPC48249
0.8214 Intermediate Similarity NPC80843
0.8214 Intermediate Similarity NPC1046
0.8214 Intermediate Similarity NPC233003
0.8214 Intermediate Similarity NPC130427
0.8214 Intermediate Similarity NPC474265
0.8214 Intermediate Similarity NPC471245
0.8214 Intermediate Similarity NPC210420
0.8198 Intermediate Similarity NPC255655
0.8198 Intermediate Similarity NPC124053
0.8198 Intermediate Similarity NPC242611
0.8198 Intermediate Similarity NPC98633
0.8197 Intermediate Similarity NPC146857
0.8197 Intermediate Similarity NPC116075
0.8197 Intermediate Similarity NPC247190
0.8197 Intermediate Similarity NPC469749
0.8197 Intermediate Similarity NPC32793
0.819 Intermediate Similarity NPC473645
0.819 Intermediate Similarity NPC58267
0.819 Intermediate Similarity NPC470312
0.819 Intermediate Similarity NPC267694
0.819 Intermediate Similarity NPC144644
0.819 Intermediate Similarity NPC142151
0.819 Intermediate Similarity NPC153673
0.819 Intermediate Similarity NPC110385
0.819 Intermediate Similarity NPC473555
0.819 Intermediate Similarity NPC471770
0.819 Intermediate Similarity NPC263674
0.819 Intermediate Similarity NPC278939
0.819 Intermediate Similarity NPC261372
0.819 Intermediate Similarity NPC37860
0.8182 Intermediate Similarity NPC38217
0.8182 Intermediate Similarity NPC472988
0.8182 Intermediate Similarity NPC473517
0.8182 Intermediate Similarity NPC295980
0.8182 Intermediate Similarity NPC258323
0.8174 Intermediate Similarity NPC105800
0.8174 Intermediate Similarity NPC232237
0.8167 Intermediate Similarity NPC311534
0.8165 Intermediate Similarity NPC165405
0.8165 Intermediate Similarity NPC26798
0.8158 Intermediate Similarity NPC472718
0.8158 Intermediate Similarity NPC244127
0.8158 Intermediate Similarity NPC477031
0.8151 Intermediate Similarity NPC469750
0.8151 Intermediate Similarity NPC250556
0.8148 Intermediate Similarity NPC213190
0.8142 Intermediate Similarity NPC285086
0.8142 Intermediate Similarity NPC475208
0.8142 Intermediate Similarity NPC471252
0.8142 Intermediate Similarity NPC178981
0.8142 Intermediate Similarity NPC238935
0.8142 Intermediate Similarity NPC132668
0.8142 Intermediate Similarity NPC251309
0.8136 Intermediate Similarity NPC41129
0.8131 Intermediate Similarity NPC477172
0.8131 Intermediate Similarity NPC31346
0.813 Intermediate Similarity NPC329636
0.8125 Intermediate Similarity NPC477073
0.8125 Intermediate Similarity NPC122339
0.8125 Intermediate Similarity NPC114188
0.8125 Intermediate Similarity NPC270586
0.8125 Intermediate Similarity NPC329953
0.8125 Intermediate Similarity NPC473062
0.8125 Intermediate Similarity NPC469824
0.8125 Intermediate Similarity NPC292196
0.812 Intermediate Similarity NPC275225
0.812 Intermediate Similarity NPC182900
0.812 Intermediate Similarity NPC476543
0.812 Intermediate Similarity NPC293031
0.812 Intermediate Similarity NPC51099
0.812 Intermediate Similarity NPC476545
0.812 Intermediate Similarity NPC68767
0.812 Intermediate Similarity NPC249553

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC106760 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8636 High Similarity NPD8133 Approved
0.8257 Intermediate Similarity NPD6412 Phase 2
0.825 Intermediate Similarity NPD7319 Approved
0.8167 Intermediate Similarity NPD7736 Approved
0.8151 Intermediate Similarity NPD7507 Approved
0.8073 Intermediate Similarity NPD8170 Clinical (unspecified phase)
0.7934 Intermediate Similarity NPD8293 Discontinued
0.7881 Intermediate Similarity NPD8294 Approved
0.7881 Intermediate Similarity NPD8377 Approved
0.7863 Intermediate Similarity NPD7327 Approved
0.7863 Intermediate Similarity NPD7328 Approved
0.7815 Intermediate Similarity NPD8380 Approved
0.7815 Intermediate Similarity NPD8379 Approved
0.7815 Intermediate Similarity NPD8296 Approved
0.7815 Intermediate Similarity NPD8378 Approved
0.7815 Intermediate Similarity NPD8335 Approved
0.7815 Intermediate Similarity NPD8033 Approved
0.7797 Intermediate Similarity NPD7516 Approved
0.775 Intermediate Similarity NPD6370 Approved
0.7699 Intermediate Similarity NPD6686 Approved
0.7642 Intermediate Similarity NPD8171 Discontinued
0.7632 Intermediate Similarity NPD8132 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD8295 Clinical (unspecified phase)
0.7623 Intermediate Similarity NPD7492 Approved
0.7583 Intermediate Similarity NPD6059 Approved
0.7583 Intermediate Similarity NPD6054 Approved
0.7561 Intermediate Similarity NPD6616 Approved
0.7541 Intermediate Similarity NPD8328 Phase 3
0.75 Intermediate Similarity NPD7078 Approved
0.7383 Intermediate Similarity NPD8035 Phase 2
0.7383 Intermediate Similarity NPD8034 Phase 2
0.7377 Intermediate Similarity NPD6015 Approved
0.7377 Intermediate Similarity NPD7503 Approved
0.7377 Intermediate Similarity NPD6016 Approved
0.7317 Intermediate Similarity NPD5988 Approved
0.7295 Intermediate Similarity NPD6319 Approved
0.7143 Intermediate Similarity NPD8297 Approved
0.7143 Intermediate Similarity NPD6882 Approved
0.7143 Intermediate Similarity NPD7520 Clinical (unspecified phase)
0.7054 Intermediate Similarity NPD6084 Phase 2
0.7054 Intermediate Similarity NPD6083 Phase 2
0.7049 Intermediate Similarity NPD6009 Approved
0.7031 Intermediate Similarity NPD6033 Approved
0.699 Remote Similarity NPD6928 Phase 2
0.6984 Remote Similarity NPD6067 Discontinued
0.696 Remote Similarity NPD8515 Approved
0.696 Remote Similarity NPD8513 Phase 3
0.696 Remote Similarity NPD8517 Approved
0.696 Remote Similarity NPD8516 Approved
0.6952 Remote Similarity NPD4788 Approved
0.6949 Remote Similarity NPD7320 Approved
0.6949 Remote Similarity NPD5345 Clinical (unspecified phase)
0.6942 Remote Similarity NPD4632 Approved
0.6923 Remote Similarity NPD6402 Approved
0.6923 Remote Similarity NPD5956 Approved
0.6923 Remote Similarity NPD7128 Approved
0.6923 Remote Similarity NPD6675 Approved
0.6923 Remote Similarity NPD5739 Approved
0.6891 Remote Similarity NPD6373 Approved
0.6891 Remote Similarity NPD6372 Approved
0.6847 Remote Similarity NPD6399 Phase 3
0.6842 Remote Similarity NPD7638 Approved
0.6838 Remote Similarity NPD4056 Clinical (unspecified phase)
0.6838 Remote Similarity NPD4057 Clinical (unspecified phase)
0.6829 Remote Similarity NPD6940 Discontinued
0.6807 Remote Similarity NPD6899 Approved
0.6807 Remote Similarity NPD6881 Approved
0.6789 Remote Similarity NPD7513 Clinical (unspecified phase)
0.6783 Remote Similarity NPD7640 Approved
0.6783 Remote Similarity NPD7639 Approved
0.678 Remote Similarity NPD6008 Approved
0.6777 Remote Similarity NPD8413 Clinical (unspecified phase)
0.6777 Remote Similarity NPD6650 Approved
0.6777 Remote Similarity NPD8130 Phase 1
0.6777 Remote Similarity NPD6649 Approved
0.6774 Remote Similarity NPD7115 Discovery
0.6726 Remote Similarity NPD5695 Phase 3
0.6723 Remote Similarity NPD5701 Approved
0.6723 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6723 Remote Similarity NPD5697 Approved
0.6696 Remote Similarity NPD5696 Approved
0.6694 Remote Similarity NPD6883 Approved
0.6694 Remote Similarity NPD4634 Approved
0.6694 Remote Similarity NPD7290 Approved
0.6694 Remote Similarity NPD7102 Approved
0.6667 Remote Similarity NPD3702 Approved
0.6641 Remote Similarity NPD8336 Approved
0.6641 Remote Similarity NPD8337 Approved
0.6639 Remote Similarity NPD6617 Approved
0.6639 Remote Similarity NPD6869 Approved
0.6639 Remote Similarity NPD6847 Approved
0.6636 Remote Similarity NPD6903 Approved
0.6635 Remote Similarity NPD6697 Approved
0.6635 Remote Similarity NPD6114 Approved
0.6635 Remote Similarity NPD6115 Approved
0.6635 Remote Similarity NPD6118 Approved
0.6612 Remote Similarity NPD6014 Approved
0.6612 Remote Similarity NPD6013 Approved
0.6612 Remote Similarity NPD6012 Approved
0.6606 Remote Similarity NPD7334 Approved
0.6606 Remote Similarity NPD6684 Approved
0.6606 Remote Similarity NPD6409 Approved
0.6606 Remote Similarity NPD5330 Approved
0.6606 Remote Similarity NPD7521 Approved
0.6606 Remote Similarity NPD7146 Approved
0.6589 Remote Similarity NPD7604 Phase 2
0.6585 Remote Similarity NPD6053 Discontinued
0.6579 Remote Similarity NPD6356 Clinical (unspecified phase)
0.6577 Remote Similarity NPD4753 Phase 2
0.6567 Remote Similarity NPD8449 Approved
0.6562 Remote Similarity NPD5983 Phase 2
0.6538 Remote Similarity NPD6116 Phase 1
0.6529 Remote Similarity NPD6011 Approved
0.6519 Remote Similarity NPD8450 Suspended
0.6504 Remote Similarity NPD6401 Clinical (unspecified phase)
0.6491 Remote Similarity NPD7748 Approved
0.6489 Remote Similarity NPD6336 Discontinued
0.6475 Remote Similarity NPD4061 Clinical (unspecified phase)
0.6466 Remote Similarity NPD7902 Approved
0.6466 Remote Similarity NPD4755 Approved
0.646 Remote Similarity NPD7637 Suspended
0.6455 Remote Similarity NPD6098 Approved
0.6442 Remote Similarity NPD6117 Approved
0.6441 Remote Similarity NPD1700 Approved
0.6434 Remote Similarity NPD6921 Approved
0.6429 Remote Similarity NPD6904 Approved
0.6429 Remote Similarity NPD6673 Approved
0.6429 Remote Similarity NPD6080 Approved
0.6423 Remote Similarity NPD6371 Approved
0.6422 Remote Similarity NPD3665 Phase 1
0.6422 Remote Similarity NPD3666 Approved
0.6422 Remote Similarity NPD3133 Approved
0.6422 Remote Similarity NPD4786 Approved
0.6408 Remote Similarity NPD6113 Clinical (unspecified phase)
0.6404 Remote Similarity NPD4202 Approved
0.6387 Remote Similarity NPD7632 Discontinued
0.6378 Remote Similarity NPD8137 Clinical (unspecified phase)
0.6373 Remote Similarity NPD5777 Approved
0.6356 Remote Similarity NPD5285 Approved
0.6356 Remote Similarity NPD5286 Approved
0.6356 Remote Similarity NPD4700 Approved
0.6356 Remote Similarity NPD4696 Approved
0.6339 Remote Similarity NPD6672 Approved
0.6339 Remote Similarity NPD5737 Approved
0.633 Remote Similarity NPD3670 Clinical (unspecified phase)
0.633 Remote Similarity NPD3669 Approved
0.6319 Remote Similarity NPD7625 Phase 1
0.6316 Remote Similarity NPD5284 Approved
0.6316 Remote Similarity NPD7983 Approved
0.6316 Remote Similarity NPD7515 Phase 2
0.6316 Remote Similarity NPD6411 Approved
0.6316 Remote Similarity NPD5281 Approved
0.6316 Remote Similarity NPD8074 Phase 3
0.6299 Remote Similarity NPD6274 Approved
0.6293 Remote Similarity NPD5210 Approved
0.6293 Remote Similarity NPD7991 Discontinued
0.6293 Remote Similarity NPD4629 Approved
0.629 Remote Similarity NPD5955 Clinical (unspecified phase)
0.6279 Remote Similarity NPD4522 Approved
0.6279 Remote Similarity NPD7100 Approved
0.6279 Remote Similarity NPD7101 Approved
0.6275 Remote Similarity NPD4244 Approved
0.6275 Remote Similarity NPD4245 Approved
0.6271 Remote Similarity NPD4225 Approved
0.625 Remote Similarity NPD5225 Approved
0.625 Remote Similarity NPD5226 Approved
0.625 Remote Similarity NPD7524 Approved
0.625 Remote Similarity NPD5211 Phase 2
0.625 Remote Similarity NPD5224 Approved
0.625 Remote Similarity NPD4633 Approved
0.6239 Remote Similarity NPD4223 Phase 3
0.6239 Remote Similarity NPD3667 Approved
0.6239 Remote Similarity NPD4221 Approved
0.623 Remote Similarity NPD4767 Approved
0.623 Remote Similarity NPD4768 Approved
0.6228 Remote Similarity NPD46 Approved
0.6228 Remote Similarity NPD6698 Approved
0.6228 Remote Similarity NPD5207 Approved
0.6226 Remote Similarity NPD7799 Discontinued
0.6216 Remote Similarity NPD5329 Approved
0.6207 Remote Similarity NPD5282 Discontinued
0.6207 Remote Similarity NPD6001 Approved
0.6207 Remote Similarity NPD7900 Approved
0.6207 Remote Similarity NPD7901 Clinical (unspecified phase)
0.6204 Remote Similarity NPD7525 Registered
0.6204 Remote Similarity NPD8338 Approved
0.6202 Remote Similarity NPD6335 Approved
0.6198 Remote Similarity NPD5174 Approved
0.6198 Remote Similarity NPD5175 Approved
0.6195 Remote Similarity NPD5208 Approved
0.6183 Remote Similarity NPD8274 Clinical (unspecified phase)
0.6183 Remote Similarity NPD6908 Approved
0.6183 Remote Similarity NPD6291 Clinical (unspecified phase)
0.6183 Remote Similarity NPD6909 Approved
0.6176 Remote Similarity NPD3698 Phase 2
0.6174 Remote Similarity NPD5693 Phase 1
0.6174 Remote Similarity NPD6050 Approved
0.6168 Remote Similarity NPD4238 Approved
0.6168 Remote Similarity NPD4802 Phase 2
0.6167 Remote Similarity NPD5223 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data